Trials / Completed
CompletedNCT01109680
A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (estimated)
- Sponsor
- Merz Pharmaceuticals GmbH · Industry
- Sex
- Male
- Age
- 55 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
A Single Center, Open-Label Study to quantify metabolites of \[14C\]-Neramexane in plasma and urine in Healthy Male Subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Neramexane | Multiple dose Neramexane followed by single dose 14C Neramexane |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2010-04-23
- Last updated
- 2011-02-08
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01109680. Inclusion in this directory is not an endorsement.